Aarti Drugs LtdPharmaceuticalsINE767A01016Consolidated₹431.80+3.45 (+0.81%)Jun-26
Valuation
Market Cap₹3.94K Cr
TTM PE20.63x
Forward PE20.27x
PEG-10.47
Book Value₹169.70
P/B2.54x
TTM EPS₹20.93
Fwd EPS₹21.31
TTM Revenue₹2.68K Cr
TTM PAT₹191.10 Cr
TTM EBITDA₹333.31 Cr
TTM EBIT₹262.60 Cr
Last Qtr PAT₹50.13 Cr
Last Qtr EBITDA₹98.20 Cr
Last Qtr EBIT₹79.74 Cr
Profitability
ROE12.34%
ROCE12.39%
TTM NPM7.14%
TTM EBITDA %12.45%
Curr OPM7.12%
Last OPM7.66%
Curr NPM—
Last NPM—
Curr EPS₹5.49
Last EPS₹6.05
Balance sheet
Equity₹91.27 Cr
Reserve₹1.46K Cr
Total Debt₹576.83 Cr
D/E0.37x
Interest %18.39%
Curr Interest₹9.22 Cr
Price / range
Close₹431.80
vs 52W High—
vs 52W Low—
MA50—
MA200—
Returns
1D+0.81%
1W+0.77%
1M+4.60%
3M+16.66%
6M+26.61%
1Y-16.35%
2Y-17.73%
3Y-27.17%
5Y-31.17%
Diwali+3.66%
Sector peers — Pharmaceuticals
Financial Results
Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS
Standalone
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Consolidated
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Corporate Actions
Dividends, bonus issues, and stock splits